دوره 4، شماره 4 - ( 10-1399 )                   جلد 4 شماره 4 صفحات 209-211 | برگشت به فهرست نسخه ها


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kargar S, Peyvand M, Hajizadeh F. The Novel COVID-19 Infections in Iran: Management and Challenges. EBHPME. 2020; 4 (4) :209-211
URL: http://jebhpme.ssu.ac.ir/article-1-278-fa.html
The Novel COVID-19 Infections in Iran: Management and Challenges. 1. 1399; 4 (4) :209-211

URL: http://jebhpme.ssu.ac.ir/article-1-278-fa.html


چکیده:   (3812 مشاهده)
The novel coronavirus (COVID-19) was first identified in Wuhan, China, in December 2019 among a cluster of patients that presented with an unidentified form of viral pneumonia with a shared history of visiting the Huanan seafood market. The pathogen has been identified as a novel enveloped RNA Betacoronavirus that has currently been named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and has a phylogenetic similarity to SARS-CoV. The World Health Organization (WHO) declared coronavirus disease 2019 (Covid-19), caused by SARS-COV2, is a public health emergency of international concern which is a threat to all countries including Iran.
 
     
نوع مطالعه: نامه به سردبیر |
دریافت: 1399/2/28 | پذیرش: 1399/9/30 | انتشار: 1399/9/30

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA

کلیه حقوق این وب سایت متعلق به مدیریت، اقتصاد و سیاستگذاری سلامت مبتنی بر شواهد می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2017  All Rights Reserved | Evidence Based Health Policy, Management and Economics

Designed & Developed by : Yektaweb